Gilder, Gagnon, Howe & Co »

Viking Therapeutics shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2024-12-31 $671k 17k 40.24

More positions owned by Gilder, Gagnon, Howe & Co

Netflix (NFLX)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Cloudflare Cl A Com (NET)
Shopify Cl A Sub Vtg Shs (SHOP)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Roblox Corp Cl A (RBLX)
Intuitive Surgical Com New (ISRG)
Duolingo Cl A Com (DUOL)
Toast Cl A (TOST)
Quanta Services (PWR)
Natera (NTRA)
Alnylam Pharmaceuticals (ALNY)
Tko Group Holdings Cl A (TKO)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics